{'fraction_non_alphanumeric': 0.027387120651369355, 'fraction_numerical': 0.014803849000740192, 'mean_word_length': 5.377358490566038, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Biomarkers association and their predictive value in SARS-CoV-2-infected hospitalized patients at a tertiary health care center

This study investigated the association and predictive value of biomarkers in hospitalized patients with SARS-CoV-2 infection. Coronavirus disease (COVID) infection has been linked to a significant hyperinflammatory immune response described as a “cytokine storm,” which results in organ deterioration and damage. Several studies have shown that cytokine levels, notably interleukin 6, can be used as indicators of COVID-19 disease severity. This hospital-based cross-sectional study was conducted in DMIMS Medical College, Sawangi-Meghe, Wardha, from March 2020 to April 2020. The study population was confirmed adult cases of COVID-19 admitted to the hospital during the study period. A positive SARS-CoV-2 reverse transcriptase-polymerase chain reaction or rapid antigen test from a nasopharyngeal swab or other respiratory sample was defined as a confirmed SARS-CoV-2 case. A purposive sampling technique was used and a total of 100 study subjects were enrolled for the study. Our study discovered a link between hematological, coagulation, and inflammatory indicators and infection severity. However, whether these indicators have a mechanistic or causative role in illness progression has to be investigated further.